Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Dec;7(Suppl 6):S699-S701.
doi: 10.21037/tau.2018.10.18.

Treating bladder adenocarcinoma

Affiliations
Editorial

Treating bladder adenocarcinoma

Georgios Tsironis et al. Transl Androl Urol. 2018 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

Similar articles

Cited by

References

    1. Noone AM, Howlader N, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, based on November 2017 SEER data submission, posted to the SEER web site, April 2018. Available online: https://seer.cancer.gov/csr/1975_2015/
    1. Jue JS, Koru-Sengul T, Moore KJ, et al. Sociodemographic and survival disparities for histologic variants of bladder cancer. Can J Urol 2018;25:9179-85. - PubMed
    1. Chang SS, Bochner BH, Chou R, et al. Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary. J Oncol Pract 2017;13:621-5. 10.1200/JOP.2017.024919 - DOI - PubMed
    1. Alfred Witjes J, Lebret T, Comperat EM, et al. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur Urol 2017;71:462-75. 10.1016/j.eururo.2016.06.020 - DOI - PubMed
    1. Kim HS, Seo HK. Immune checkpoint inhibitors for urothelial carcinoma. Investig Clin Urol 2018;59:285-96. 10.4111/icu.2018.59.5.285 - DOI - PMC - PubMed